Ba. Baldo et Mm. Fisher, DIAGNOSIS OF IGE-DEPENDENT ANAPHYLAXIS TO NEUROMUSCULAR BLOCKING-DRUGS, THIOPENTONE AND OPIOIDS, Annales francaises d'anesthesie et de reanimation, 12(2), 1993, pp. 173-181
Although allergenic cross-reactivity of neuromuscular blocking drugs (
NMBDs) is recognised clinically and has been firmly established at the
serological and immunochemical levels, interpretation of in vitro inh
ibition findings for clinical purposes is not always straightforward.
Points to be taken into account when considering serum IgE direct bind
ing and inhibition results and when determining which NMBDs a patient
may be sensitive to, include the relationship between in vitro potenci
es and clinical findings and the nature of the drug solid phase used f
or testing. It should also be remembered that the stimulating antigeni
c source for the patients' NMBD-reactive IgE antibodies is almost alwa
ys unknown. A comparison of skin and IgE radioimmunoassay (RIA) tests
for NMBDs in 29 patients is presented and difficulties involved in int
erpreting the results of both tests are discussed. Methods for increas
ing the detection of NMBD-reactive IgE antibodies are outlined. In scr
eening sera of patients for IgE antibodies to thiopentone and morphine
as well as NMBDs, multiple drug reactivities have been detected in a
few subjects. Attention is drawn to defects in the existing thiopenton
e RIA although it is clear that the test is specific in patients who r
eact to the drug. Addition of the serum tryptase assay to skin tests a
nd IgE RIAs for NMBDs, thiopentone and morphine provides a powerful co
mbination of diagnostic tests for the investigation of anaphylactoid r
eactions to anaesthetic drugs.